BMS-191011
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


BMS-191011
Description :
BMS 191011 (BMS-A) is a potent BKCa channel opener (large-conductance Ca2+-activated potassium channel) . BMS-191011 shows neuroprotective activities in rodent models of stroke[1].Product Name Alternative :
BMS-AUNSPSC :
12352005Hazard Statement :
H301, H413Target :
Potassium ChannelType :
Reference compoundRelated Pathways :
Membrane Transporter/Ion ChannelApplications :
Neuroscience-NeuromodulationField of Research :
Neurological DiseaseAssay Protocol :
https://www.medchemexpress.com/bms-191011.htmlPurity :
99.56Solubility :
DMSO : 50 mg/mL (ultrasonic)Smiles :
O=C1OC(C2=CC=C(C(F)(F)F)C=C2)=NN1CC3=CC(Cl)=CC=C3OMolecular Formula :
C16H10ClF3N2O3Molecular Weight :
370.71Precautions :
H301, H413References & Citations :
[1]Romine JL, et al. 3-[ (5-Chloro-2-hydroxyphenyl) methyl]-5-[4- (trifluoromethyl) phenyl ]-1,3,4-oxadiazol-2 (3H) -one, BMS-191011: opener of large-conductance Ca (2+) -activated potassium (maxi-K) channels, identification, solubility, and SAR. J Med Chem. 2007 Feb 8;50 (3) :528-42.|[2]Asami Mori, et al. BMS-191011, an opener of large-conductance Ca2+-activated potassium channels, dilates rat retinal arterioles in vivo. Biol Pharm Bull. 2011;34 (1) :150-2.|[3]Remigante A, et al. NS-11021 Modulates Cancer-Associated Processes Independently of BK Channels in Melanoma and Pancreatic Duct Adenocarcinoma Cell Lines. Cancers (Basel) . 2021 Dec 6;13 (23) :6144.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedCAS Number :
[202821-81-6]

